Understanding of metastatic colorectal cancer (mCRC) in the real world: Initial results from a European survey on the unmet needs of patients living with metastatic colorectal cancer

被引：0
|
作者：
Maravic, Z. [1 ]
Wyrwicz, L. [2 ]
Karczmarek-Borowska, B. [3 ]
Basany, E. Espin [4 ]
Carrato, A. [5 ]
Horvath, A. [6 ]
aBenedict [7 ]
Kapitany, Z. [8 ]
机构：
[1] EuropaColon, Salisbury, Wilts, England
[2] Ctr Onkol Inst M Sklodowskiej Curie, Warsaw, Poland
[3] Ctr Clin Oncol Prov Hosp 1, Rzeszow, Poland
[4] Univ Autonoma Barcelona, Hosp Valle de Hebron, Barcelona, Spain
[5] Alcala Univ, Hosp Univ Ramon y Cajal, CIBERONC, IRYCIS, Madrid, Spain
[6] Semmelweis Univ, Budapest, Hungary
[7] Evidera, Budapest, Hungary
[8] Semmelweis Univ, Fac Hlth Sci, Budapest, Hungary
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 272
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [31] Treatment patterns and site of metastasis in patients with metastatic colorectal cancer (mCRC)
    Iqbal, Sheikh Usman
    Thompson, Stephen F.
    Naoshy, Sarah
    Ng, Daniel B.
    Wooten, Michael
    Sherman, Steven A.
    Malangone, Elisabetta
    Stern, Lee
    Gorritz-Kindu, Magdaliz
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Quality of life (QoL) with capecitabine in patients with metastatic colorectal cancer (MCRC)
    Beato, C. A. M.
    Van Eyll, B.
    Federico, M. H.
    Perdicaris, M. R.
    Skare, N.
    Cabral, S.
    Saltz, E.
    Franke, F.
    Moura, G. L.
    Paula, F. U.
    EJC SUPPLEMENTS, 2005, 3 (02): : 365 - 365
  • [33] Assessing QoL in patients with metastatic colorectal cancer (mCRC) treated with chemotherapy
    Miller, KL
    Johnson, LL
    Colwell, HH
    Bhattacharyya, SK
    Deeter, RG
    Mathias, SD
    VALUE IN HEALTH, 2005, 8 (06) : A49 - A49
  • [34] Treatment of metastatic colorectal cancer (mCRC) according to age
    Ortega, Laura
    Torres Perez-Solero, Gabriela
    Arregui Valles, Marta
    Alva Bianchi, Manuel
    Aparicio Salcedo, Inmaculada
    Garcia Gonzalez, Gonzalo
    Gallego Gallego, Iria
    Munoz Martin, Andres J.
    Calvo Ferrandiz, Aitana
    Blanco-Codesido, Montserrat
    Martin, Miguel
    Garcia-Alfonso, Pilar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [35] Panitumumab in Patients With Metastatic Colorectal Cancer (mCRC) - Single Center Experience
    Lopez Lopez, C.
    Novas Vidal, P.
    Gutierrez Sanz, L.
    Garicano Goldaraz, F.
    Hernandez Garcia, I.
    Vega Gil, N.
    Blanco Mesonero, Y.
    Salcedo Lambera, M.
    Rivera Herrero, F.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S429 - S429
  • [36] CLAIMS DATA ANALYSIS OF PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) IN GERMANY
    Bartsch, R.
    Zimmermann, L.
    Reis, L.
    Hecker, D.
    Lebioda, A.
    VALUE IN HEALTH, 2020, 23 : S453 - S453
  • [37] Influence of not having children on mortality in patients with metastatic (mCRC) colorectal cancer
    Ahmed, S.
    Baig, T.
    Zaidi, A.
    Chalchal, H.
    Haider, K.
    Asif, T.
    Iqbal, N.
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] Metastatic colorectal Cancer (mCRC) New Treatment Option for pretreated Patients
    Arnold, Dirk
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (09) : 577 - 577
  • [39] Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis
    Schulz, Martin S.
    Wolf, Sebastian
    Struck, Vera
    Thomas, Niklas
    Husman, Gabriele
    Zeuzem, Stefan
    Koch, Christine
    Trojan, Joerg
    Schnitzbauer, Andreas Anton
    Bechstein, Wolf Otto
    Waidmann, Oliver
    CANCERS, 2022, 14 (07)
  • [40] Real-world treatment patterns and outcomes associated with bevacizumab (bev) in metastatic colorectal cancer (mCRC).
    Saverno, Kimberly
    Walker, Mark S.
    Hennessy, Daniel
    Dhawan, Ravinder
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345